Abstract
The ubiquitin-proteasome proteolytic pathway is of major importance in the breakdown of skeletal muscle proteins. The first step in this pathway is the covalent attachment of polyubiquitin chains to the targeted protein. Polyubiquitinylated proteins are then recognized and degraded by the 26S proteasome complex. In this review, we critically analyze recent findings in the regulation of ubiquitinylation of protein substrates and of their subsequent proteasome-dependent degradation in animal models of cancer cachexia. In particular, we discuss the influence of various mediators (anorexia, hormones, prostaglandins, cytokines, and proteolysis-inducing factor) in signaling the activation of ubiquitin-proteasome proteolysis in skeletal muscle. These findings have lead to new concepts that are starting to be used for preventing cachexia in cancer and other wasting diseases.
Similar content being viewed by others
References
Tisdale MJ (1991) Br. J. Cancer 63: 337–342
Warren S (1932) Am. J. Med. Sci. 186: 610–615
Attaix D & Taillandier D (1998) Adv. Mol. Cell Biol. 27: 235–266
Jariel-Encontre I, Salvat C, Steff A-M, Pariat M, Acquaviva C, Furstoss O & Piechaczyk M (1997) Mol. Biol. Rep. 24: 51–56
Mitch WE & Goldberg AL (1996) N. Engl. J.Med. 335: 1897–1905
Huang J & Forsberg NE (1998) Proc. Natl. Acad. Sci. USA 95: 12100–12105
Solomon V & Goldberg AL (1996) J. Biol. Chem. 271: 26690–26697
Tessitore L, Bonnelli G & Baccino FM (1987) Biochem. J. 241: 153–158
Strelkov AB, Fields ALA & Baracos VE (1989) Am. J. Physiol. 257: C261–C269
Smith KL & Tisdale MJ (1993) Br. J. Cancer 67: 680–685
Lundholm K, Bylund AC, Holm J & Schersten T (1976) Eur. J. Cancer 12: 465–473
Pisters PWT & Brennan MF (1990) Annu. Rev. Nutr. 10: 107–132
O'Keefe SJD, Ogden J, Ramjee G & Rund J (1990) Cancer Res. 50: 1226–1230
Temparis S, Asensi M, Taillandier D, Aurousseau E, Larbaud D, Obled A, Béchet D, Ferrara M, Estrela JM & Attaix D (1994) Cancer Res. 54: 5568–5573
Baracos VE, DeVivo C, Hoyle DHR & Goldberg AL (1995) Am. J. Physiol. 268: E996–E1006
Lorite MJ, Thompson MG, Drake JL, Carling G & Tisdale MJ (1998) Br. J. Cancer 78: 850–856
Llovera M, Garcia-Martinez C, Agell N, Lopez-Soriano FJ & Argiles JM (1995) Int. J. Cancer 61: 138–141
Llovera M, Garcia-Martinez C, Agell N, Marzabal M, Lopez-Soriano FJ & Argiles JM (1993) FEBS Lett. 338: 311–318
Solomon V, Baracos V, Sarraf P & Goldberg AL (1998) Proc. Natl. Acad. Sci. USA 95: 12602–12607
Wing SS, Haas AL & Goldberg AL (1995) Biochem. J. 307: 639–645
Furuno K, Goodman MN & Goldberg AL (1990) J. Biol. Chem. 265: 8550–8557
Tiao G, Fagan JM, Samuels N, James JH, Hudson K, Lieberman M, Fischer JE & Hasselgren PO (1994) J. Clin. Invest. 94: 2255–2264
Hobler SC, Tiao G, Fischer JE, Monaco J & Hasselgren PO (1998) Am. J. Physiol. 274: R30–R37
Price SR, Bailey JL, Wang X, Jurkovitz C, England BK, Ding X, Phillips LS, Mitch WE (1996) J. Clin. Invest. 98: 1703–1708
Tawa NE Jr, Odessey R, Goldberg AL (1997) J. Clin. Invest. 100: 197–203
Coux O, Tanaka K & Goldberg AL (1996) Annu. Rev. Biochem. 65: 801–847
Hendil KB, Khan S & Tanaka K (1998) Biochem. J. 332: 749–754
Attaix D, Taillandier D, Combaret L, Ralliè re C, Larbaud D, Aurousseau E & Tanaka K (1997) Mol. Biol. Rep. 24: 95–98
Combaret C, Ralliè re C, Taillandier D, Tanaka K & Attaix D (1999) Mol. Biol. Rep. 26: 95–101
Dawson SP, Arnold JE, Mayer NJ, Reynolds SE, Billett MA, Gordon C, Colleaux L, Kloetzel PM, Tanaka K & Mayer RJ (1995) J. Biol. Chem. 270: 1850–1858
Llovera M, Garcia-Martinez C, Costelli P, Agell N, Carbo N, Lopez-Soriano FJ & Argiles JM (1996) Cancer Lett. 99: 7–14
Tiao G, Fagan JM, Roegner V, Lieberman M, Wang JJ, Fischer JE, & Hasselgren P-O (1996) J. Clin. Invest. 97: 339–348.
Strelkov AB, Fields ALA & Baracos VE (1989) Am. J. Physiol. 257: C261–C269
Garcia-Martinez C, Llovera M, Agell N, Lopez-Soriano FJ & Argiles JM (1994) Biochem. Biophys. Res. Commun. 201: 682–686
Llovera M, Carbo N, Garcia-Martinez C, Costelli P, Tessitore L, Baccino FM, Agell N, Bagby GJ, Lopez-Soriano F & Argiles JM (1996) Biochem. Biophys. Res. Commun. 221: 653–655
Llovera M, Garcia-Martinez C, Agell N, Lopez-Soriano FJ & Argiles JM (1997) Biochem. Biophys. Res. Commun. 230: 238–241
Li Y-P, Schwartz RJ, Waddell ID, Holloway BR & Reid MB (1998) FASEB J. 12: 871–880
Llovera M, Carbo N, Lopez-Soriano J, Garcia-Martinez C, Busquets S, Alvarez B, Costelli P, Lopez-Soriano FJ, Celada A & Argiles JM (1998) Cancer Lett. 133: 83–87
Costelli P, Garcia-Martinez C, Llovera M, Carbo N, Lopez-Soriano FJ, Agell N, Tessitore L, Baccino FM & Argiles JM (1995) J. Clin. Invest. 95: 2367–2372
Mansoor O, Beaufrè re B, Boirie Y, Ralliè re C, Taillandier D, Aurousseau E, Schoeffler P, Arnal M & Attaix D (1996) Proc. Natl. Acad. Sci. USA 93: 2714–2718
Tiao G, Hobler S, Wang JJ, Meyer TA, Luchette FA, Fischer JE, Hasselgren PO (1997) J. Clin. Invest. 99: 163–168
Llovera M, Garcia-Martinez C, Agell N, Lopez-Soriano FJ, Authier FJ, Gherardi RK & Argiles JM (1998) Int. J. Mol. Med. 2: 69–73
Fujiki F, Mukaida N, Hirose K, Ishida H, Harada A, Ohno S, Bluethmann H, Kawakami M, Akiyama M, Sone S & Matsushima K (1997) Cancer Res. 57: 94–99
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Attaix, D., Combaret, L., Tilignac, T. et al. Adaptation of the ubiquitin-proteasome proteolytic pathway in cancer cachexia. Mol Biol Rep 26, 77–82 (1999). https://doi.org/10.1023/A:1006961919775
Issue Date:
DOI: https://doi.org/10.1023/A:1006961919775